miR-205 regulates basement membrane deposition in human prostate: implications for cancer development

被引:77
|
作者
Gandellini, P. [1 ]
Profumo, V. [1 ]
Casamichele, A. [1 ]
Fenderico, N. [1 ]
Borrelli, S. [2 ]
Petrovich, G. [2 ]
Santilli, G. [1 ]
Callari, M. [1 ]
Colecchia, M. [3 ]
Pozzi, S. [2 ]
De Cesare, M. [1 ]
Folini, M. [1 ]
Valdagni, R. [4 ,5 ]
Mantovani, R. [2 ]
Zaffaroni, N. [1 ]
机构
[1] Fdn IRCCS, Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[2] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy
[3] Fdn IRCCS, Ist Nazl Tumori, Dept Pathol, I-20133 Milan, Italy
[4] Fdn IRCCS, Ist Nazl Tumori, Dept Radiotherapy, I-20133 Milan, Italy
[5] Fdn IRCCS, Ist Nazl Tumori, Prostate Program, I-20133 Milan, Italy
来源
CELL DEATH AND DIFFERENTIATION | 2012年 / 19卷 / 11期
关键词
microRNA; prostate cancer; p63; basal layer of epithelium; basement membrane; 3D culture; EPITHELIAL-CELL LINES; STEM-CELLS; MICRORNA EXPRESSION; DOWN-REGULATION; P63; REVEALS; FAMILY; REQUIREMENTS; SURVIVAL; DISTINCT;
D O I
10.1038/cdd.2012.56
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The basement membrane (BM) is a layer of specialized extracellular matrix that surrounds normal prostate glands and preserves tissue integrity. Lack or discontinuity of the BM is a prerequisite for tumor cell invasion into interstitial spaces, thus favoring metastasis. Therefore, BM maintenance represents a barrier against cancer development and progression. In the study, we show that miR-205 participates in a network involving Delta Np63 alpha, which is essential for maintenance of the BM in prostate epithelium. At the molecular level, Delta Np63 alpha is able to enhance miR-205 transcription by binding to its promoter, whereas the microRNA can post-transcriptionally limit the amount of Delta Np63a protein, mostly by affecting Delta Np63 alpha proteasomal degradation rather than through a canonical miRNA/target interaction. Functionally, miR-205 is able to control the deposition of laminin-332 and its receptor integrin-beta 4. Hence, pathological loss of miR-205, as widely observed in prostate cancer, may favor tumorigenesis by creating discontinuities in the BM. Here we demonstrate that therapeutic replacement of miR-205 in prostate cancer (PCa) cells can restore BM deposition and 3D organization into normal-like acinar structures, thus hampering cancer progression. Cell Death and Differentiation (2012) 19, 1750-1760; doi:10.1038/cdd.2012.56; published online 4 May 2012
引用
收藏
页码:1750 / 1760
页数:11
相关论文
共 50 条
  • [1] miR-205 regulates basement membrane deposition in human prostate: implications for cancer development
    P Gandellini
    V Profumo
    A Casamichele
    N Fenderico
    S Borrelli
    G Petrovich
    G Santilli
    M Callari
    M Colecchia
    S Pozzi
    M De Cesare
    M Folini
    R Valdagni
    R Mantovani
    N Zaffaroni
    Cell Death & Differentiation, 2012, 19 : 1750 - 1760
  • [2] A role for miR-205 in prostate cancer
    Place, Robert
    Noonan, Emily
    Li, Long-Cheng
    CANCER RESEARCH, 2009, 69
  • [3] The ups and downs of miR-205 Identifying the roles of miR-205 in mammary gland development and breast cancer
    Greene, Stephanie B.
    Herschkowitz, Jason I.
    Rosen, Jeffrey M.
    RNA BIOLOGY, 2010, 7 (03) : 300 - 304
  • [4] miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
    Z Hagman
    B S Haflidadóttir
    J A Ceder
    O Larne
    A Bjartell
    H Lilja
    A Edsjö
    Y Ceder
    British Journal of Cancer, 2013, 108 : 1668 - 1676
  • [5] miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
    Hagman, Z.
    Haflidadottir, B. S.
    Ceder, J. A.
    Larne, O.
    Bjartell, A.
    Lilja, H.
    Edsjo, A.
    Ceder, Y.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1668 - 1676
  • [6] Epigenetic regulation of miR-31 and miR-205 of apoptosis in prostate cancer
    Zhang, Qunshu
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Investigation of miR-205 expression and its methylation status in prostate cancer
    Lynch, Seodhna M.
    O'Neill, Karla M.
    McKenna, Michael M.
    Walsh, Colum P.
    Watson, William
    Gallagher, William M.
    McKenna, Declan J.
    CANCER RESEARCH, 2018, 78 (13)
  • [8] miR-205 replenishment in prostate cancer cells: A novel nanoparticle approach
    Nagesh, Prashanth K.
    Chowdhury, Pallabita
    Boya, Vijayakumar N.
    Kashyap, Vivek K.
    Khan, Sheema
    Hafeez, Bilal B.
    Zafar, Nadeem
    Behrman, Stephen W.
    Chauhan, Subhash C.
    Jaggi, Meena
    Yallapu, Murali M.
    CANCER RESEARCH, 2017, 77
  • [9] MiR-205 in cancer: An angel or a devil?
    Qin, Ai-Ying
    Zhang, Xin-Wei
    Liu, Liang
    Yu, Jin-Pu
    Li, Hui
    Wang, Shi-Zhen Emily
    Ren, Xiu-Bao
    Cao, Shui
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2013, 92 (02) : 54 - 60
  • [10] Targeting miR-205 in breast cancer
    Wu, Hailong
    Mo, Yin-Yuan
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (12) : 1439 - 1448